Starbloom Capital
Investment FirmNew York, USASee on the mapstarbloom.capital
Starbloom Capital is an investment firm focused on deep-tech innovations, including longevity biotech, neuroAI, and emerging industries.
- 2
- Portfolio companies on reccy
- 2
- Hiring now
- 26
- Open roles in the portfolio
- Mar 2026
- Latest portfolio round
Hiring now in the portfolio26
Apply on each company's site- Posted 1d ago
Clinical Data Scientist
Cognito Therapeutics · Cambridge, MA - Hybrid
- Posted 1d ago
Clinical Trial Assistant
Cognito Therapeutics · Cambridge, MA - Hybrid
- Posted 1d ago
Senior Biostatistician
Cognito Therapeutics · US - Remote
- Posted 1d ago
Director, Design Quality
Cognito Therapeutics · Cambridge, MA - Hybrid
- Posted 1d ago
Director, Quality Systems
Cognito Therapeutics · Cambridge, MA - Hybrid
- Posted 1d ago
Director, Supplier Quality
Cognito Therapeutics · Cambridge, MA - Hybrid
- Posted 1d ago
Quality Engineer
Cognito Therapeutics · US - Remote
- Posted 4d ago
Senior Vice President, Clinical Operations & Development
Cognito Therapeutics · Cambridge, MA - Hybrid
Portfolio on reccy2
From company funding recordsTheir companies, round by round
From company funding records- Cognito TherapeuticsCambridge, Massachusetts
Digital therapeutics
- Mar 2026Series C · $105MLed
- Jan 2024Series B · $35M
- Mar 2023Series B · $73M
- Jun 2022Venture Round · $109M
- BexorgSan Francisco, CA
- Oct 2026Grant · $28.3M
- Oct 2025Series A · $42.5MLed
- Jun 2025SeedLed
Rounds marked Led list Starbloom Capital as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Mar 2026
Cognito Therapeutics · Series C $105MLead
With Morningside
- Oct 2025
Bexorg · Series A $42.5MLead
With The Engine, Connecticut Innovations, E1 Ventures, Amplify Partners, Little Engine Ventures
- Jun 2025
Bexorg · SeedLead
With Amplify Partners
Portfolio in the news
From the Cortex · last 12 months- Nov 2026
- Nov 2026
- Nov 2026
- Nov 2026
- Oct 2026Bexorg appoints Mikael Dolsten as chairman of board
Bexorg · Medical Buyer
- Oct 2026